Clinical application of asparaginase activity levels following treatment with pegaspargase

E-ISSN： 1545-5017|62|6|1102-1105

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.6, 2015-06, pp. : 1102-1105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic and clinical considerations for monitoring asparaginase activity levels during pegaspargase therapy

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 6, 2015-06 ,pp. : 1115-1115

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to: Colon LB, Perissinotti A, Santarosa M, Marini BL. Pharmacokinetic and clinical considerations for monitoring asparaginase activity levels during pegaspargase therapy

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 6, 2015-06 ,pp. : 1116-1116

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 3, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Elevated Homocysteine Levels on Clinical Restenosis following Percutaneous Coronary Intervention

Cardiology, Vol. 97, Iss. 4, 2002-07 ,pp. : 214-217

Karger

Access to resources Recommend Favorite

Clinical significance of serum cortisol levels following surgery for congenital heart disease

Cardiology in the Young, Vol. 27, Iss. 2, 2016-04 ,pp. : 318-324

Cambridge University Press

Access to resources Recommend Favorite